How Protocol Optimization Improves Clinical Trial Outcomes

November 22, 2017

Protocols are the foundation of effective clinical trials — targeting potential recruits, dosages, end points and much more. Human studies must have practically doable, well-thought-out protocols,
but the complexities of bringing new drugs to market make it extremely difficult for protocols to anticipate all the ways a trial can go astray.  In this article,  Sy Pretorius, chief scientific officer at Parexel International, offers a new framework for protocol optimization.
Previous Flipbook
Beware the Seductions of M&A
Beware the Seductions of M&A

No More Flipbooks